Business Segments — Total revenues
Incyte Business Segments — Total revenues decreased by 15.5% to $1.27B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.9%, from $1.05B to $1.27B. Over 3 years (FY 2022 to FY 2025), Business Segments — Total revenues shows an upward trend with a 14.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful market penetration and strong demand for the company's drug portfolio, while a decrease may signal competitive pressure or patent expirations.
Detailed definition
This represents the aggregate gross income generated by the company's primary business segment through product sales, ro...
Peer comparison
Standard across all biopharmaceutical companies as the primary measure of top-line performance.
incy_segment_reportable_segment_total_revenuesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $848.66M | $848.66M | $848.66M | $848.66M | $923.91M | $923.91M | $923.91M | $923.91M | $880.89M | $1.04B | $1.14B | $1.18B | $1.05B | $1.22B | $1.37B | $1.51B | $1.27B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +8.9% | +0.0% | +0.0% | +0.0% | -4.7% | +18.5% | +9.0% | +3.6% | -10.7% | +15.4% | +12.4% | +10.3% | -15.5% |
| YoY Change | — | — | — | — | +8.9% | +8.9% | +8.9% | +8.9% | -4.7% | +13.0% | +23.2% | +27.6% | +19.5% | +16.5% | +20.0% | +27.8% | +20.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Incyte's business segments — total revenues?
- Incyte (INCY) reported business segments — total revenues of $1.27B in Q1 2026.
- How has Incyte's business segments — total revenues changed year-over-year?
- Incyte's business segments — total revenues increased by 20.9% year-over-year, from $1.05B to $1.27B.
- What is the long-term trend for Incyte's business segments — total revenues?
- Over 3 years (2022 to 2025), Incyte's business segments — total revenues has grown at a 14.8% compound annual growth rate (CAGR), from $3.39B to $5.14B.
- What does business segments — total revenues mean?
- The total income generated by the company's main business operations.